Phase 1a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RN5681 in Healthy Volunteers
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of single doses of RN5681 in Adult healthy subjects
Body mass index (BMI) 18 to 35 kg/m2 [+4]
Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) >1.5× the upp... [+4]